 | • レポートコード：MRC2Q12-17910 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、マイクロ流体イムノアッセイ システムの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にマイクロ流体イムノアッセイ システムのグローバル市場のxxx％を占める「マイクロ流体解析装置」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 マイクロ流体イムノアッセイ システムの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのマイクロ流体イムノアッセイ システム市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 マイクロ流体イムノアッセイ システムのグローバル主要プレイヤーには、Abbott Laboratories、Quidel Corporation、Abaxis、Nanōmix、Koninklijke Philips、Biosurfit SA、Micropoint Bioscience、Siloam Biosciences、NanoEnTek、OPKO Healthなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 マイクロ流体イムノアッセイ システム市場は、種類と用途によって区分されます。世界のマイクロ流体イムノアッセイ システム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 マイクロ流体解析装置、マイクロ流体カートリッジ、その他 【用途別セグメント】 病院、研究所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - マイクロ流体イムノアッセイ システム製品概要 - 種類別市場（マイクロ流体解析装置、マイクロ流体カートリッジ、その他） - 用途別市場（病院、研究所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のマイクロ流体イムノアッセイ システム販売量予測2017-2028 - 世界のマイクロ流体イムノアッセイ システム売上予測2017-2028 - マイクロ流体イムノアッセイ システムの地域別販売量 - マイクロ流体イムノアッセイ システムの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別マイクロ流体イムノアッセイ システム販売量 - 主要メーカー別マイクロ流体イムノアッセイ システム売上 - 主要メーカー別マイクロ流体イムノアッセイ システム価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（マイクロ流体解析装置、マイクロ流体カートリッジ、その他） - マイクロ流体イムノアッセイ システムの種類別販売量 - マイクロ流体イムノアッセイ システムの種類別売上 - マイクロ流体イムノアッセイ システムの種類別価格 ・用途別市場規模（病院、研究所、その他） - マイクロ流体イムノアッセイ システムの用途別販売量 - マイクロ流体イムノアッセイ システムの用途別売上 - マイクロ流体イムノアッセイ システムの用途別価格 ・北米市場 - 北米のマイクロ流体イムノアッセイ システム市場規模（種類別、用途別） - 主要国別のマイクロ流体イムノアッセイ システム市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのマイクロ流体イムノアッセイ システム市場規模（種類別、用途別） - 主要国別のマイクロ流体イムノアッセイ システム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のマイクロ流体イムノアッセイ システム市場規模（種類別、用途別） - 主要国別のマイクロ流体イムノアッセイ システム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のマイクロ流体イムノアッセイ システム市場規模（種類別、用途別） - 主要国別のマイクロ流体イムノアッセイ システム市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのマイクロ流体イムノアッセイ システム市場規模（種類別、用途別） - 主要国別のマイクロ流体イムノアッセイ システム市場規模（トルコ、サウジアラビア） ・企業情報 Abbott Laboratories、Quidel Corporation、Abaxis、Nanōmix、Koninklijke Philips、Biosurfit SA、Micropoint Bioscience、Siloam Biosciences、NanoEnTek、OPKO Health ・産業チェーン及び販売チャネル分析 - マイクロ流体イムノアッセイ システムの産業チェーン分析 - マイクロ流体イムノアッセイ システムの原材料 - マイクロ流体イムノアッセイ システムの生産プロセス - マイクロ流体イムノアッセイ システムの販売及びマーケティング - マイクロ流体イムノアッセイ システムの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - マイクロ流体イムノアッセイ システムの産業動向 - マイクロ流体イムノアッセイ システムのマーケットドライバー - マイクロ流体イムノアッセイ システムの課題 - マイクロ流体イムノアッセイ システムの阻害要因 ・主な調査結果 |
Microfluidic immunoassay systems are used for disease diagnostic, environmental monitoring, and food and drug screening.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Microfluidic Immunoassay System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Microfluidic Immunoassay System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Microfluidic Immunoassay System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Microfluidic Immunoassay System include Abbott Laboratories, Quidel Corporation, Abaxis, Nanōmix, Koninklijke Philips, Biosurfit SA, Micropoint Bioscience, Siloam Biosciences and NanoEnTek, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Microfluidic Immunoassay System manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Microfluidic Immunoassay System market. Further, it explains the major drivers and regional dynamics of the global Microfluidic Immunoassay System market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Abbott Laboratories
Quidel Corporation
Abaxis
Nanōmix
Koninklijke Philips
Biosurfit SA
Micropoint Bioscience
Siloam Biosciences
NanoEnTek
OPKO Health
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Microfluidic Immunoassay System Segment by Type
Microfluidic Analyzers
Microfluidic Cartridges
Other
Microfluidic Immunoassay System Segment by Application
Hospital
Laboratory
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Microfluidic Immunoassay System market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Microfluidic Immunoassay System, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Microfluidic Immunoassay System, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Microfluidic Immunoassay System, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Microfluidic Immunoassay System sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Microfluidic Immunoassay System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Microfluidic Immunoassay System sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Laboratories, Quidel Corporation, Abaxis, Nanōmix, Koninklijke Philips, Biosurfit SA, Micropoint Bioscience, Siloam Biosciences and NanoEnTek, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Microfluidic Immunoassay System in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Microfluidic Immunoassay System manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microfluidic Immunoassay System sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Microfluidic Immunoassay System Product Introduction
1.2 Market by Type
1.2.1 Global Microfluidic Immunoassay System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Microfluidic Analyzers
1.2.3 Microfluidic Cartridges
1.2.4 Other
1.3 Market by Application
1.3.1 Global Microfluidic Immunoassay System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Microfluidic Immunoassay System Sales Estimates and Forecasts 2017-2028
2.2 Global Microfluidic Immunoassay System Revenue Estimates and Forecasts 2017-2028
2.3 Global Microfluidic Immunoassay System Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Microfluidic Immunoassay System Sales by Region
2.4.1 Global Microfluidic Immunoassay System Sales by Region (2017-2022)
2.4.2 Global Sales Microfluidic Immunoassay System by Region (2023-2028)
2.5 Global Microfluidic Immunoassay System Revenue by Region
2.5.1 Global Microfluidic Immunoassay System Revenue by Region (2017-2022)
2.5.2 Global Microfluidic Immunoassay System Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Microfluidic Immunoassay System Sales by Manufacturers
3.1.1 Global Top Microfluidic Immunoassay System Manufacturers by Sales (2017-2022)
3.1.2 Global Microfluidic Immunoassay System Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Microfluidic Immunoassay System in 2021
3.2 Global Microfluidic Immunoassay System Revenue by Manufacturers
3.2.1 Global Microfluidic Immunoassay System Revenue by Manufacturers (2017-2022)
3.2.2 Global Microfluidic Immunoassay System Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Microfluidic Immunoassay System Revenue in 2021
3.3 Global Microfluidic Immunoassay System Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Microfluidic Immunoassay System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Microfluidic Immunoassay System Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Microfluidic Immunoassay System Sales by Type
4.1.1 Global Microfluidic Immunoassay System Historical Sales by Type (2017-2022)
4.1.2 Global Microfluidic Immunoassay System Forecasted Sales by Type (2023-2028)
4.1.3 Global Microfluidic Immunoassay System Sales Market Share by Type (2017-2028)
4.2 Global Microfluidic Immunoassay System Revenue by Type
4.2.1 Global Microfluidic Immunoassay System Historical Revenue by Type (2017-2022)
4.2.2 Global Microfluidic Immunoassay System Forecasted Revenue by Type (2023-2028)
4.2.3 Global Microfluidic Immunoassay System Revenue Market Share by Type (2017-2028)
4.3 Global Microfluidic Immunoassay System Price by Type
4.3.1 Global Microfluidic Immunoassay System Price by Type (2017-2022)
4.3.2 Global Microfluidic Immunoassay System Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Microfluidic Immunoassay System Sales by Application
5.1.1 Global Microfluidic Immunoassay System Historical Sales by Application (2017-2022)
5.1.2 Global Microfluidic Immunoassay System Forecasted Sales by Application (2023-2028)
5.1.3 Global Microfluidic Immunoassay System Sales Market Share by Application (2017-2028)
5.2 Global Microfluidic Immunoassay System Revenue by Application
5.2.1 Global Microfluidic Immunoassay System Historical Revenue by Application (2017-2022)
5.2.2 Global Microfluidic Immunoassay System Forecasted Revenue by Application (2023-2028)
5.2.3 Global Microfluidic Immunoassay System Revenue Market Share by Application (2017-2028)
5.3 Global Microfluidic Immunoassay System Price by Application
5.3.1 Global Microfluidic Immunoassay System Price by Application (2017-2022)
5.3.2 Global Microfluidic Immunoassay System Price Forecast by Application (2023-2028)
6 North America
6.1 North America Microfluidic Immunoassay System Market Size by Type
6.1.1 North America Microfluidic Immunoassay System Sales by Type (2017-2028)
6.1.2 North America Microfluidic Immunoassay System Revenue by Type (2017-2028)
6.2 North America Microfluidic Immunoassay System Market Size by Application
6.2.1 North America Microfluidic Immunoassay System Sales by Application (2017-2028)
6.2.2 North America Microfluidic Immunoassay System Revenue by Application (2017-2028)
6.3 North America Microfluidic Immunoassay System Market Size by Country
6.3.1 North America Microfluidic Immunoassay System Sales by Country (2017-2028)
6.3.2 North America Microfluidic Immunoassay System Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Microfluidic Immunoassay System Market Size by Type
7.1.1 Europe Microfluidic Immunoassay System Sales by Type (2017-2028)
7.1.2 Europe Microfluidic Immunoassay System Revenue by Type (2017-2028)
7.2 Europe Microfluidic Immunoassay System Market Size by Application
7.2.1 Europe Microfluidic Immunoassay System Sales by Application (2017-2028)
7.2.2 Europe Microfluidic Immunoassay System Revenue by Application (2017-2028)
7.3 Europe Microfluidic Immunoassay System Market Size by Country
7.3.1 Europe Microfluidic Immunoassay System Sales by Country (2017-2028)
7.3.2 Europe Microfluidic Immunoassay System Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Microfluidic Immunoassay System Market Size by Type
8.1.1 Asia Pacific Microfluidic Immunoassay System Sales by Type (2017-2028)
8.1.2 Asia Pacific Microfluidic Immunoassay System Revenue by Type (2017-2028)
8.2 Asia Pacific Microfluidic Immunoassay System Market Size by Application
8.2.1 Asia Pacific Microfluidic Immunoassay System Sales by Application (2017-2028)
8.2.2 Asia Pacific Microfluidic Immunoassay System Revenue by Application (2017-2028)
8.3 Asia Pacific Microfluidic Immunoassay System Market Size by Region
8.3.1 Asia Pacific Microfluidic Immunoassay System Sales by Region (2017-2028)
8.3.2 Asia Pacific Microfluidic Immunoassay System Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Microfluidic Immunoassay System Market Size by Type
9.1.1 Latin America Microfluidic Immunoassay System Sales by Type (2017-2028)
9.1.2 Latin America Microfluidic Immunoassay System Revenue by Type (2017-2028)
9.2 Latin America Microfluidic Immunoassay System Market Size by Application
9.2.1 Latin America Microfluidic Immunoassay System Sales by Application (2017-2028)
9.2.2 Latin America Microfluidic Immunoassay System Revenue by Application (2017-2028)
9.3 Latin America Microfluidic Immunoassay System Market Size by Country
9.3.1 Latin America Microfluidic Immunoassay System Sales by Country (2017-2028)
9.3.2 Latin America Microfluidic Immunoassay System Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Microfluidic Immunoassay System Market Size by Type
10.1.1 Middle East and Africa Microfluidic Immunoassay System Sales by Type (2017-2028)
10.1.2 Middle East and Africa Microfluidic Immunoassay System Revenue by Type (2017-2028)
10.2 Middle East and Africa Microfluidic Immunoassay System Market Size by Application
10.2.1 Middle East and Africa Microfluidic Immunoassay System Sales by Application (2017-2028)
10.2.2 Middle East and Africa Microfluidic Immunoassay System Revenue by Application (2017-2028)
10.3 Middle East and Africa Microfluidic Immunoassay System Market Size by Country
10.3.1 Middle East and Africa Microfluidic Immunoassay System Sales by Country (2017-2028)
10.3.2 Middle East and Africa Microfluidic Immunoassay System Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Overview
11.1.3 Abbott Laboratories Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott Laboratories Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Laboratories Recent Developments
11.2 Quidel Corporation
11.2.1 Quidel Corporation Corporation Information
11.2.2 Quidel Corporation Overview
11.2.3 Quidel Corporation Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Quidel Corporation Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Quidel Corporation Recent Developments
11.3 Abaxis
11.3.1 Abaxis Corporation Information
11.3.2 Abaxis Overview
11.3.3 Abaxis Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abaxis Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abaxis Recent Developments
11.4 Nanōmix
11.4.1 Nanōmix Corporation Information
11.4.2 Nanōmix Overview
11.4.3 Nanōmix Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Nanōmix Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Nanōmix Recent Developments
11.5 Koninklijke Philips
11.5.1 Koninklijke Philips Corporation Information
11.5.2 Koninklijke Philips Overview
11.5.3 Koninklijke Philips Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Koninklijke Philips Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Koninklijke Philips Recent Developments
11.6 Biosurfit SA
11.6.1 Biosurfit SA Corporation Information
11.6.2 Biosurfit SA Overview
11.6.3 Biosurfit SA Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Biosurfit SA Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Biosurfit SA Recent Developments
11.7 Micropoint Bioscience
11.7.1 Micropoint Bioscience Corporation Information
11.7.2 Micropoint Bioscience Overview
11.7.3 Micropoint Bioscience Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Micropoint Bioscience Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Micropoint Bioscience Recent Developments
11.8 Siloam Biosciences
11.8.1 Siloam Biosciences Corporation Information
11.8.2 Siloam Biosciences Overview
11.8.3 Siloam Biosciences Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Siloam Biosciences Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Siloam Biosciences Recent Developments
11.9 NanoEnTek
11.9.1 NanoEnTek Corporation Information
11.9.2 NanoEnTek Overview
11.9.3 NanoEnTek Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 NanoEnTek Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 NanoEnTek Recent Developments
11.10 OPKO Health
11.10.1 OPKO Health Corporation Information
11.10.2 OPKO Health Overview
11.10.3 OPKO Health Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 OPKO Health Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 OPKO Health Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Microfluidic Immunoassay System Industry Chain Analysis
12.2 Microfluidic Immunoassay System Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Microfluidic Immunoassay System Production Mode & Process
12.4 Microfluidic Immunoassay System Sales and Marketing
12.4.1 Microfluidic Immunoassay System Sales Channels
12.4.2 Microfluidic Immunoassay System Distributors
12.5 Microfluidic Immunoassay System Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Microfluidic Immunoassay System Industry Trends
13.2 Microfluidic Immunoassay System Market Drivers
13.3 Microfluidic Immunoassay System Market Challenges
13.4 Microfluidic Immunoassay System Market Restraints
14 Key Findings in The Global Microfluidic Immunoassay System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Microfluidic Immunoassay System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Microfluidic Analyzers
Table 3. Major Manufacturers of Microfluidic Cartridges
Table 4. Major Manufacturers of Other
Table 5. Global Microfluidic Immunoassay System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Microfluidic Immunoassay System Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Microfluidic Immunoassay System Sales by Region (2017-2022) & (K Units)
Table 8. Global Microfluidic Immunoassay System Sales Market Share by Region (2017-2022)
Table 9. Global Microfluidic Immunoassay System Sales by Region (2023-2028) & (K Units)
Table 10. Global Microfluidic Immunoassay System Sales Market Share by Region (2023-2028)
Table 11. Global Microfluidic Immunoassay System Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Microfluidic Immunoassay System Revenue Market Share by Region (2017-2022)
Table 13. Global Microfluidic Immunoassay System Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Microfluidic Immunoassay System Revenue Market Share by Region (2023-2028)
Table 15. Global Microfluidic Immunoassay System Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Microfluidic Immunoassay System Sales Share by Manufacturers (2017-2022)
Table 17. Global Microfluidic Immunoassay System Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Microfluidic Immunoassay System Revenue Share by Manufacturers (2017-2022)
Table 19. Microfluidic Immunoassay System Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Microfluidic Immunoassay System Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Microfluidic Immunoassay System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microfluidic Immunoassay System as of 2021)
Table 22. Microfluidic Immunoassay System Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Microfluidic Immunoassay System Product Offered
Table 24. Date of Manufacturers Enter into Microfluidic Immunoassay System Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Microfluidic Immunoassay System Sales by Type (2017-2022) & (K Units)
Table 27. Global Microfluidic Immunoassay System Sales by Type (2023-2028) & (K Units)
Table 28. Global Microfluidic Immunoassay System Sales Share by Type (2017-2022)
Table 29. Global Microfluidic Immunoassay System Sales Share by Type (2023-2028)
Table 30. Global Microfluidic Immunoassay System Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Microfluidic Immunoassay System Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Microfluidic Immunoassay System Revenue Share by Type (2017-2022)
Table 33. Global Microfluidic Immunoassay System Revenue Share by Type (2023-2028)
Table 34. Microfluidic Immunoassay System Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Microfluidic Immunoassay System Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Microfluidic Immunoassay System Sales by Application (2017-2022) & (K Units)
Table 37. Global Microfluidic Immunoassay System Sales by Application (2023-2028) & (K Units)
Table 38. Global Microfluidic Immunoassay System Sales Share by Application (2017-2022)
Table 39. Global Microfluidic Immunoassay System Sales Share by Application (2023-2028)
Table 40. Global Microfluidic Immunoassay System Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Microfluidic Immunoassay System Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Microfluidic Immunoassay System Revenue Share by Application (2017-2022)
Table 43. Global Microfluidic Immunoassay System Revenue Share by Application (2023-2028)
Table 44. Microfluidic Immunoassay System Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Microfluidic Immunoassay System Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Microfluidic Immunoassay System Sales by Type (2017-2022) & (K Units)
Table 47. North America Microfluidic Immunoassay System Sales by Type (2023-2028) & (K Units)
Table 48. North America Microfluidic Immunoassay System Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Microfluidic Immunoassay System Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Microfluidic Immunoassay System Sales by Application (2017-2022) & (K Units)
Table 51. North America Microfluidic Immunoassay System Sales by Application (2023-2028) & (K Units)
Table 52. North America Microfluidic Immunoassay System Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Microfluidic Immunoassay System Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Microfluidic Immunoassay System Sales by Country (2017-2022) & (K Units)
Table 55. North America Microfluidic Immunoassay System Sales by Country (2023-2028) & (K Units)
Table 56. North America Microfluidic Immunoassay System Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Microfluidic Immunoassay System Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Microfluidic Immunoassay System Sales by Type (2017-2022) & (K Units)
Table 59. Europe Microfluidic Immunoassay System Sales by Type (2023-2028) & (K Units)
Table 60. Europe Microfluidic Immunoassay System Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Microfluidic Immunoassay System Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Microfluidic Immunoassay System Sales by Application (2017-2022) & (K Units)
Table 63. Europe Microfluidic Immunoassay System Sales by Application (2023-2028) & (K Units)
Table 64. Europe Microfluidic Immunoassay System Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Microfluidic Immunoassay System Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Microfluidic Immunoassay System Sales by Country (2017-2022) & (K Units)
Table 67. Europe Microfluidic Immunoassay System Sales by Country (2023-2028) & (K Units)
Table 68. Europe Microfluidic Immunoassay System Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Microfluidic Immunoassay System Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Microfluidic Immunoassay System Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Microfluidic Immunoassay System Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Microfluidic Immunoassay System Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Microfluidic Immunoassay System Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Microfluidic Immunoassay System Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Microfluidic Immunoassay System Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Microfluidic Immunoassay System Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Microfluidic Immunoassay System Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Microfluidic Immunoassay System Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Microfluidic Immunoassay System Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Microfluidic Immunoassay System Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Microfluidic Immunoassay System Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Microfluidic Immunoassay System Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Microfluidic Immunoassay System Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Microfluidic Immunoassay System Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Microfluidic Immunoassay System Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Microfluidic Immunoassay System Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Microfluidic Immunoassay System Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Microfluidic Immunoassay System Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Microfluidic Immunoassay System Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Microfluidic Immunoassay System Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Microfluidic Immunoassay System Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Microfluidic Immunoassay System Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Microfluidic Immunoassay System Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Microfluidic Immunoassay System Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Microfluidic Immunoassay System Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Microfluidic Immunoassay System Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Microfluidic Immunoassay System Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Microfluidic Immunoassay System Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Microfluidic Immunoassay System Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Microfluidic Immunoassay System Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Microfluidic Immunoassay System Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Microfluidic Immunoassay System Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Microfluidic Immunoassay System Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Microfluidic Immunoassay System Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Microfluidic Immunoassay System Revenue by Country (2023-2028) & (US$ Million)
Table 106. Abbott Laboratories Corporation Information
Table 107. Abbott Laboratories Description and Major Businesses
Table 108. Abbott Laboratories Microfluidic Immunoassay System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Abbott Laboratories Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Abbott Laboratories Recent Developments
Table 111. Quidel Corporation Corporation Information
Table 112. Quidel Corporation Description and Major Businesses
Table 113. Quidel Corporation Microfluidic Immunoassay System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Quidel Corporation Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Quidel Corporation Recent Developments
Table 116. Abaxis Corporation Information
Table 117. Abaxis Description and Major Businesses
Table 118. Abaxis Microfluidic Immunoassay System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Abaxis Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Abaxis Recent Developments
Table 121. Nanōmix Corporation Information
Table 122. Nanōmix Description and Major Businesses
Table 123. Nanōmix Microfluidic Immunoassay System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Nanōmix Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Nanōmix Recent Developments
Table 126. Koninklijke Philips Corporation Information
Table 127. Koninklijke Philips Description and Major Businesses
Table 128. Koninklijke Philips Microfluidic Immunoassay System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Koninklijke Philips Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Koninklijke Philips Recent Developments
Table 131. Biosurfit SA Corporation Information
Table 132. Biosurfit SA Description and Major Businesses
Table 133. Biosurfit SA Microfluidic Immunoassay System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Biosurfit SA Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Biosurfit SA Recent Developments
Table 136. Micropoint Bioscience Corporation Information
Table 137. Micropoint Bioscience Description and Major Businesses
Table 138. Micropoint Bioscience Microfluidic Immunoassay System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Micropoint Bioscience Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Micropoint Bioscience Recent Developments
Table 141. Siloam Biosciences Corporation Information
Table 142. Siloam Biosciences Description and Major Businesses
Table 143. Siloam Biosciences Microfluidic Immunoassay System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Siloam Biosciences Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Siloam Biosciences Recent Developments
Table 146. NanoEnTek Corporation Information
Table 147. NanoEnTek Description and Major Businesses
Table 148. NanoEnTek Microfluidic Immunoassay System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. NanoEnTek Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. NanoEnTek Recent Developments
Table 151. OPKO Health Corporation Information
Table 152. OPKO Health Description and Major Businesses
Table 153. OPKO Health Microfluidic Immunoassay System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. OPKO Health Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. OPKO Health Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Microfluidic Immunoassay System Distributors List
Table 159. Microfluidic Immunoassay System Customers List
Table 160. Microfluidic Immunoassay System Market Trends
Table 161. Microfluidic Immunoassay System Market Drivers
Table 162. Microfluidic Immunoassay System Market Challenges
Table 163. Microfluidic Immunoassay System Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Microfluidic Immunoassay System Product Picture
Figure 2. Global Microfluidic Immunoassay System Market Share by Type in 2021 & 2028
Figure 3. Microfluidic Analyzers Product Picture
Figure 4. Microfluidic Cartridges Product Picture
Figure 5. Other Product Picture
Figure 6. Global Microfluidic Immunoassay System Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Laboratory
Figure 9. Other
Figure 10. Microfluidic Immunoassay System Report Years Considered
Figure 11. Global Microfluidic Immunoassay System Sales 2017-2028 (K Units)
Figure 12. Global Microfluidic Immunoassay System Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Microfluidic Immunoassay System Revenue 2017-2028 (US$ Million)
Figure 14. Global Microfluidic Immunoassay System Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Microfluidic Immunoassay System Sales Market Share by Region (2017-2022)
Figure 16. Global Microfluidic Immunoassay System Sales Market Share by Region (2023-2028)
Figure 17. North America Microfluidic Immunoassay System Sales YoY (2017-2028) & (K Units)
Figure 18. North America Microfluidic Immunoassay System Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Microfluidic Immunoassay System Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Microfluidic Immunoassay System Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Microfluidic Immunoassay System Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Microfluidic Immunoassay System Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Microfluidic Immunoassay System Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Microfluidic Immunoassay System Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Microfluidic Immunoassay System Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Microfluidic Immunoassay System Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Microfluidic Immunoassay System Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Microfluidic Immunoassay System in the World: Market Share by Microfluidic Immunoassay System Revenue in 2021
Figure 29. Global Microfluidic Immunoassay System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Microfluidic Immunoassay System Sales Market Share by Type (2017-2028)
Figure 31. Global Microfluidic Immunoassay System Revenue Market Share by Type (2017-2028)
Figure 32. Global Microfluidic Immunoassay System Sales Market Share by Application (2017-2028)
Figure 33. Global Microfluidic Immunoassay System Revenue Market Share by Application (2017-2028)
Figure 34. North America Microfluidic Immunoassay System Sales Market Share by Type (2017-2028)
Figure 35. North America Microfluidic Immunoassay System Revenue Market Share by Type (2017-2028)
Figure 36. North America Microfluidic Immunoassay System Sales Market Share by Application (2017-2028)
Figure 37. North America Microfluidic Immunoassay System Revenue Market Share by Application (2017-2028)
Figure 38. North America Microfluidic Immunoassay System Sales Share by Country (2017-2028)
Figure 39. North America Microfluidic Immunoassay System Revenue Share by Country (2017-2028)
Figure 40. United States Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Microfluidic Immunoassay System Sales Market Share by Type (2017-2028)
Figure 43. Europe Microfluidic Immunoassay System Revenue Market Share by Type (2017-2028)
Figure 44. Europe Microfluidic Immunoassay System Sales Market Share by Application (2017-2028)
Figure 45. Europe Microfluidic Immunoassay System Revenue Market Share by Application (2017-2028)
Figure 46. Europe Microfluidic Immunoassay System Sales Share by Country (2017-2028)
Figure 47. Europe Microfluidic Immunoassay System Revenue Share by Country (2017-2028)
Figure 48. Germany Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 49. France Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Microfluidic Immunoassay System Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Microfluidic Immunoassay System Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Microfluidic Immunoassay System Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Microfluidic Immunoassay System Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Microfluidic Immunoassay System Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Microfluidic Immunoassay System Revenue Share by Region (2017-2028)
Figure 59. China Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 62. India Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Microfluidic Immunoassay System Sales Market Share by Type (2017-2028)
Figure 69. Latin America Microfluidic Immunoassay System Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Microfluidic Immunoassay System Sales Market Share by Application (2017-2028)
Figure 71. Latin America Microfluidic Immunoassay System Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Microfluidic Immunoassay System Sales Share by Country (2017-2028)
Figure 73. Latin America Microfluidic Immunoassay System Revenue Share by Country (2017-2028)
Figure 74. Mexico Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 77. Colombia Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Microfluidic Immunoassay System Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Microfluidic Immunoassay System Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Microfluidic Immunoassay System Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Microfluidic Immunoassay System Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Microfluidic Immunoassay System Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Microfluidic Immunoassay System Revenue Share by Country (2017-2028)
Figure 84. Turkey Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Microfluidic Immunoassay System Revenue (2017-2028) & (US$ Million)
Figure 87. Microfluidic Immunoassay System Value Chain
Figure 88. Microfluidic Immunoassay System Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed